Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 17;18(1):88.
doi: 10.1186/s40246-024-00656-y.

Shaping the future of kidney genetics in Australia: proceedings from the KidGen policy implementation workshop 2023

Affiliations

Shaping the future of kidney genetics in Australia: proceedings from the KidGen policy implementation workshop 2023

Amali Mallawaarachchi et al. Hum Genomics. .

Abstract

The KidGen Collaborative's Policy Implementation Workshop 2023 celebrated the 10th anniversary of Australia's first kidney genetics clinic in Brisbane. This event marked the establishment of a national network now comprising 19 kidney genetics clinics across Australia, all dedicated to providing equitable access to genomic testing for families affected by genetic kidney diseases. The workshop reflected on past progress and outlined future objectives for kidney genetics in Australia, recognising the collaborative efforts of clinical teams, researchers, and patients. Key insights from the workshop are documented in the proceedings.

Keywords: Creative problem-solving; Genomic testing; KidGen; Kidney disease; Personalised medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Navigating the Genomic Landscape in Nephrology: Advancing Precision Care. Informed by their real-world nephrology experiences, KidGen Workshop participants emphasised the need for greater involvement of genetic counsellors and patient representatives in shaping future healthcare models. While challenges like resourcing, consenting, and counselling exist, the participants also identified enablers such as telehealth, stewardship, and decision aids. They recommended organising regular brain trust meetings and creating secondary pathways for genetically undiagnosed but well-phenotyped patients as integral components of future models
Fig. 2
Fig. 2
Kidney Genomic Study: Overview and Study Flow. The study aims to use advanced genomic testing to deliver genetic diagnoses to previously undiagnosed individuals in clinical networks. A. It accepts both paediatric and adult patients. The diagram describes the inclusion criteria, such as referral by a nephrologist or clinical geneticist, and the exclusion criteria, including non-familial GKD. It also includes advice for doctors and genetic counsellors regarding patient inclusion in the study. The leaflet mentions several resources, including the Participation Information & Consent Form and the Australian Genomic Consent Fact Sheet. A QR code is provided for rapid access to nominations; however, nominations must not include identifiable information. B. The process begins with a new patient or re-analysing a de-identified recruitment database. The clinical team assesses patients based on predefined criteria, determining inclusion, exclusion, or the need for further information. Following a multidisciplinary team (MDT) review, patients are either enrolled in the study or not recruited. Enrolled patients' data are then transferred to a study database for sample testing, which may involve various sequencing methods. The researcher obtained and communicated the results to the local clinician and patient within 12 months
Fig. 3
Fig. 3
Visualizing Interactive Reasoning in Crafting the Future of Care for Genetic Kidney Diseases. This diagram, collaboratively developed during the KidGen Workshop, encapsulates discussions about the imperative for innovative therapies within well-structured clinical trials for patients facing genetic kidney diseases. Undertaking this intricate task involves the collective efforts of various stakeholders, such as government institutions, clinicians, families, educational activities, and funding bodies, working synergistically towards a shared goal: better lives for patients with genetic kidney diseases

References

    1. Jayasinghe K, et al. Implementation and evaluation of a national multidisciplinary kidney genetics clinic network over 10 years. Kidney International Reports. 2024. 10.1016/j.ekir.2024.04.068.10.1016/j.ekir.2024.04.068 - DOI
    1. Mallawaarachchi AC, et al. Genomic testing in patients with kidney failure of an unknown cause: a national australian study. Clin J Am Soc Nephrol. 2024. 10.2215/CJN.0000000000000464. 10.2215/CJN.0000000000000464 - DOI - PMC - PubMed
    1. Stark Z, Scott RH. Genomic newborn screening for rare diseases. Nat Rev Genet. 2023;24(11):755–66. 10.1038/s41576-023-00621-w. 10.1038/s41576-023-00621-w - DOI - PubMed
    1. Mallett A, et al. A multidisciplinary renal genetics clinic improves patient diagnosis. Med J Aust. 2016;204(2):58–9. 10.5694/mja15.01157. 10.5694/mja15.01157 - DOI - PubMed
    1. Alkanderi S, et al. Lessons learned from a multidisciplinary renal genetics clinic. QJM. 2017;110(7):453–7. 10.1093/qjmed/hcx030. 10.1093/qjmed/hcx030 - DOI - PubMed

Publication types

LinkOut - more resources